El potencial de las benzodiacepinas para provocar eventos adversos como caídas, fracturas, deterioro cognitivo, (...) y delirio, está bien documentado
Reducción
Lukacisinová et al. The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different Europeon countries and Israel: retrospective results from the EU SHEL TER study. BMJ Geriatrics. (2021) 21:277
Disminución
La evidencia sobre la efectividad de las benzodiacepinas, especialmente para el tratamiento a largo plazo del insomnio, es cuestionable.
Glass et al. Sedative hypnotics in older people with insomnio: meta-analysis of risks and benefits. BMJ. 2005:331(7526):1169
Desprescripción
"Estos medicamentos pueden representar riesgos reales y a menudo hay alternativas más seguras disponibles. Nuestros hallazgos sugieren enérgicamente que necesitamos estrategias para reducir el uso de benzodiacepinas"
Olfson et al. Benzodiazepine Use in the United States. JAMA Psychiatry. 2014 Dec 17
Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedativehypnotic use to improve patient SAFEty and quality of care.
Datos y opiniones sobre BSH
Aspectos destacados
Choosing Wisely Canada’s National Meeting
Choosing Wisely Canada’s National Meeting will return to an in-person event on May 11 and 12, 2023. Join us in Toronto at the Globe and Mail Centre for two days of engaging keynote speakers, workshops, and breakout sessions.
Videos destacados
Benzodiazepine Tapers in Primary Care - Kendall Shibuya, D.O.
The Seattle Science Foundation is a not for profit organization dedicated to advancing the quality of patient care through education, research, innovation and technology. As a physician driven organization, we have created a trusted community of nationally recognized experts from the world’s best medical and academic institutions.
